Nordea sees bright future for Bavarian Nordic's vaccine sales - medwatch.com
From the original
Nordea sees bright future for Bavarian Nordic's vaccine sales medwatch.com
Related speeches
4 itemsDanske Bank ups its outlook for Novo's Wegovy pill - medwatch.com
Positive outlook at Demant prompts Nordea to raise its price target - medwatch.com
Nordea Bank Abp stock (FI4000297767): Summer 2026 outlook update and Nordic banking backdrop - AD HOC NEWS
How financing startups became a success
The desk believes that the Nordic region is emerging as a beacon for startup financing, bolstered by Nordea's systematic approach to risk assessment and investor integration. Per the full note from Nordea, their strategy has led to a record-high €11.9 billion invested in Nordic startups in 2021, underlining the region's potential to shape the business landscape of the future. This positive narrative aligns with our current targets for the Nordic currencies, positioning them favorably amid a robust venture capital environment.
More like this
5 itemsUSD/JPY Forecast: Yen Strength Puts 152 Support in Focus as BoJ Tightening Looms - BeInCrypto
New Zealand Dollar languishes near two-month low vs USD as bears await break below 0.5700 - Bitget
Bonds & bold: The refi won't be the reaper - Nordea Corporate
Equities: Strong rebound supported by earnings growth – Danske Bank - FXStreet